1,064 filings
Page 37 of 54
10-Q
2012 Q1
EYPT
EyePoint Pharmaceuticals Inc
Quarterly report
8 Nov 11
12:00am
8-K
EYPT
EyePoint Pharmaceuticals Inc
7 Nov 11
Psivida Corp. Reports Results for the First Quarter
12:00am
8-K
EYPT
EyePoint Pharmaceuticals Inc
3 Nov 11
Other Events
12:00am
424B3
EYPT
EyePoint Pharmaceuticals Inc
3 Nov 11
Prospectus supplement
12:00am
DEF 14A
EYPT
EyePoint Pharmaceuticals Inc
Definitive proxy
25 Oct 11
12:00am
PRE 14A
EYPT
EyePoint Pharmaceuticals Inc
Preliminary proxy
29 Sep 11
12:00am
10-K
2011 FY
EYPT
EyePoint Pharmaceuticals Inc
Annual report
13 Sep 11
12:00am
8-K
EYPT
EyePoint Pharmaceuticals Inc
12 Sep 11
Other Events
12:00am
8-K
EYPT
EyePoint Pharmaceuticals Inc
12 Sep 11
Psivida Corp. Reports Fourth Quarter
12:00am
8-K
EYPT
EyePoint Pharmaceuticals Inc
20 Jun 11
Entry into a Material Definitive Agreement
12:00am
10-Q
2011 Q3
EYPT
EyePoint Pharmaceuticals Inc
Quarterly report
11 May 11
12:00am
8-K
EYPT
EyePoint Pharmaceuticals Inc
10 May 11
Psivida Corp. Reports Results for the Third Quarter
12:00am
8-K
EYPT
EyePoint Pharmaceuticals Inc
3 May 11
Psivida Announces New Safety and Efficacy Data from Phase 3
12:00am
10-Q
2011 Q2
EYPT
EyePoint Pharmaceuticals Inc
Quarterly report
10 Feb 11
12:00am
8-K
EYPT
EyePoint Pharmaceuticals Inc
9 Feb 11
Psivida Corp. Reports Results for the Second Quarter
12:00am
8-K
EYPT
EyePoint Pharmaceuticals Inc
3 Feb 11
Psivida Announces Positive Results from the 36 Month Readout of Completed Phase 3 Fameā¢ Study of IluvienĀ® In Patients with Diabetic Macular Edema
12:00am
424B5
EYPT
EyePoint Pharmaceuticals Inc
21 Jan 11
Prospectus supplement for primary offering
12:00am
8-K
EYPT
EyePoint Pharmaceuticals Inc
21 Jan 11
Other Events
12:00am
424B5
EYPT
EyePoint Pharmaceuticals Inc
19 Jan 11
Prospectus supplement for primary offering
12:00am